FSA & HSA eligible
Affordable weight loss plans through Hims
Personalized weight loss plans with a range of treatment options, like oral medication kits starting at $69/mo1
Transparent, all-in pricing
No hidden fees
100% online, no in-person visit required
1. Pay upfront in full. Actual price to customer will depend on product and subscription plan purchase.
Compounded drug products are not FDA-approved. FDA does not evaluate compounded products for safety, effectiveness, or quality.
Ozempic® (semaglutide), Mounjaro® (tirzepatide), and Generic Liraglutide are not compounded. Ozempic®, Mounjaro®, and Generic Liraglutide are FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight loss at a healthcare provider's discretion. Ozempic® is a registered trademark of Novo Nordisk A/S. Mounjaro® is a registered trademarks of Eli Lilly and Company. Hims, Inc. is not affiliated with or endorsed by Novo Nordisk A/S or Eli Lilly and Company.
Prescription products require an online consultation with a healthcare provider who will determine if a prescription is appropriate.
FSA/HSA eligibility and coverage varies by plan provider.